Literature DB >> 33443197

Effectiveness of chest pain centre accreditation on the management of acute coronary syndrome: a retrospective study using a national database.

Pengfei Sun1, Jianping Li1, Weiyi Fang2, Xi Su3, Bo Yu4,5, Yan Wang6, Chunjie Li7, Hu Chen8, Xingang Wang1, Bin Zhang1, Yuxi Li1, Mohetaboer Momin1, Ying Shi9, Haibo Wang10, Yan Zhang11, Dingcheng Xiang12, Yong Huo11.   

Abstract

BACKGROUND: Large-scale real-world data to evaluate the impact of chest pain centre (CPC) accreditation on acute coronary syndrome (ACS) emergency care in heavy-burden developing countries like China are rare.
METHODS: This study is a retrospective study based on data from the Hospital Quality Monitoring System (HQMS) database. This study included emergency patients admitted with ACS to hospitals that uploaded clinical data continuously to the database from 2013 to 2016. Propensity score matching was used to compare hospitals with and without CPC accreditation during this period. A longitudinal self-contrast comparison design with mixed-effects models was used to compare management of ACS before and after accreditation.
RESULTS: A total of 798 008 patients with ACS from 746 hospitals were included in the analysis. After matching admission date, hospital levels and types and adjusting for possible covariates, patients with ACS admitted to accredited CPCs had lower in-hospital mortality (OR=0.70, 95% CI 0.53 to 0.93), shorter length of stay (LOS; adjusted multiplicative effect=0.89, 95% CI 0.84 to 0.94) and more percutaneous coronary intervention (PCI) procedures (OR=3.53, 95% CI 2.20 to 5.66) than patients admitted in hospitals without applying for CPC accreditation. Furthermore, when compared with the 'before accreditation' group only in accredited CPCs, the in-hospital mortality and LOS decreased and the usage of PCI were increased in both 'accreditation' (for in-hospital mortality: OR=0.86, 95% CI 0.79 to 0.93; for LOS: 0.94, 95% CI 0.93 to 0.95; for PCI: OR=1.22, 95% CI 1.18 to 1.26) and 'after accreditation' groups (for in-hospital mortality: OR=0.90, 95% CI 0.84 to 0.97; for LOS: 0.89, 95% CI 0.89 to 0.90; for PCI: OR=1.36, 95% CI 1.33 to 1.39). The significant benefits of decreased in-hospital mortality, reduced LOS and increased PCI usage were also observed for patients with acute myocardial infarction.
CONCLUSIONS: CPC accreditation is associated with better management and in-hospital clinical outcomes of patients with ACS. CPC establishment and accreditation should be promoted and implemented in countries with high levels of ACS. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  healthcare quality improvement; medical emergency team; quality improvement; teamwork

Mesh:

Year:  2020        PMID: 33443197     DOI: 10.1136/bmjqs-2020-011491

Source DB:  PubMed          Journal:  BMJ Qual Saf        ISSN: 2044-5415            Impact factor:   7.035


  6 in total

1.  Trends and sex differences in atrial fibrillation hospitalization and catheter ablation at tertiary hospitals in China from 2013 to 2016.

Authors:  Kang Li; Fang-Fang Fan; Peng-Fei Sun; Jie Jiang; Jing Zhou; Ying Shi; Hai-Bo Wang; Jian-Ping Li; Yan Zhang; Yong Huo
Journal:  J Geriatr Cardiol       Date:  2022-04-28       Impact factor: 3.189

2.  A Novel Risk Score to Predict In-Hospital Mortality in Patients With Acute Myocardial Infarction: Results From a Prospective Observational Cohort.

Authors:  Lulu Li; Xiling Zhang; Yini Wang; Xi Yu; Haibo Jia; Jingbo Hou; Chunjie Li; Wenjuan Zhang; Wei Yang; Bin Liu; Lixin Lu; Ning Tan; Bo Yu; Kang Li
Journal:  Front Cardiovasc Med       Date:  2022-04-07

3.  Machine learning to predict no reflow and in-hospital mortality in patients with ST-segment elevation myocardial infarction that underwent primary percutaneous coronary intervention.

Authors:  Lianxiang Deng; Xianming Zhao; Xiaolin Su; Mei Zhou; Daizheng Huang; Xiaocong Zeng
Journal:  BMC Med Inform Decis Mak       Date:  2022-04-24       Impact factor: 3.298

4.  Reperfusion strategy and in-hospital outcomes for ST elevation myocardial infarction in secondary and tertiary hospitals in predominantly rural central China: a multicentre, prospective and observational study.

Authors:  You Zhang; Shan Wang; Qianqian Cheng; Junhui Zhang; Datun Qi; Xianpei Wang; Zhongyu Zhu; Muwei Li; Dayi Hu; Chuanyu Gao
Journal:  BMJ Open       Date:  2021-12-20       Impact factor: 2.692

5.  Reperfusion Strategy of ST-Elevation Myocardial Infarction: A Meta-Analysis of Primary Percutaneous Coronary Intervention and Pharmaco-Invasive Therapy.

Authors:  Kaiyin Li; Bin Zhang; Bo Zheng; Yan Zhang; Yong Huo
Journal:  Front Cardiovasc Med       Date:  2022-03-17

6.  Factors Associated With Medical Staff's Engagement and Perception of a Quality Improvement Program for Acute Coronary Syndromes in Hospitals: A Nationally Representative Mixed-Methods Study in China.

Authors:  Shuduo Zhou; Yinzi Jin; Junxiong Ma; Xuejie Dong; Na Li; Hong Shi; Yan Zhang; Xiaoyu Guan; Kenneth A LaBresh; Sidney C Smith; Yong Huo; Zhi-Jie Zheng
Journal:  J Am Heart Assoc       Date:  2022-03-30       Impact factor: 6.106

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.